ATC Group: D06BX01 Metronidazole

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of D06BX01 in the ATC hierarchy

Level Code Title
1 D Dermatologicals
2 D06 Antibiotics and chemotherapeutics for dermatological use
3 D06B Chemotherapeutics for topical use
4 D06BX Other chemotherapeutics
5 D06BX01 Metronidazole

Active ingredients in D06BX01

Active Ingredient

Metronidazole is an anti-infectious drug belonging to the pharmacotherapeutic group of nitroimidazole derivatives, which have effect mainly on strict anaerobes. This effect is probably caused by interaction with DNS and different metabolites.

Related product monographs

Document Type Information Source  
 METROGEL Gel MPI, US: SPL/PLR FDA, National Drug Code (US)
 METROSA Gel MPI, EU: SmPC European Medicines Agency (EU)
 ROSICED Cream MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 ROZEX Cream MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

United States medicines

Medicines classified under this ATC code globally

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Finland (FI)

France (FR)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Japan (JP)

Lithuania (LT)

Malta (MT)

Netherlands (NL)

New Zealand (NZ)

Poland (PL)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.